These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 25446140)

  • 1. Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
    Velkov T; Abdul Rahim N; Zhou QT; Chan HK; Li J
    Adv Drug Deliv Rev; 2015 May; 85():65-82. PubMed ID: 25446140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled formulations and pulmonary drug delivery systems for respiratory infections.
    Zhou QT; Leung SS; Tang P; Parumasivam T; Loh ZH; Chan HK
    Adv Drug Deliv Rev; 2015 May; 85():83-99. PubMed ID: 25451137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled antimicrobial therapy - barriers to effective treatment.
    Weers J
    Adv Drug Deliv Rev; 2015 May; 85():24-43. PubMed ID: 25193067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled Antibiotics for Gram-Negative Respiratory Infections.
    Wenzler E; Fraidenburg DR; Scardina T; Danziger LH
    Clin Microbiol Rev; 2016 Jul; 29(3):581-632. PubMed ID: 27226088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled antimicrobial chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
    Chan HK; Li J
    Adv Drug Deliv Rev; 2015 May; 85():v-vii. PubMed ID: 25907147
    [No Abstract]   [Full Text] [Related]  

  • 6. Challenges and strategies in drug delivery systems for treatment of pulmonary infections.
    Ho DK; Nichols BLB; Edgar KJ; Murgia X; Loretz B; Lehr CM
    Eur J Pharm Biopharm; 2019 Nov; 144():110-124. PubMed ID: 31493510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of antibiotics to the respiratory tract: an update.
    Traini D; Young PM
    Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled ciprofloxacin for chronic airways infections caused by Pseudomonas aeruginosa.
    Antonela Antoniu S
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1439-46. PubMed ID: 23253321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The false dichotomy of viral versus bacterial aetiology in upper respiratory tract infections.
    Davis JS; Magin PJ; van Driel ML
    Med J Aust; 2019 Aug; 211(3):108-109.e1. PubMed ID: 31232463
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary drug delivery systems for antimicrobial agents: facts and myths.
    Falagas ME; Michalopoulos A; Metaxas EI
    Int J Antimicrob Agents; 2010 Feb; 35(2):101-6. PubMed ID: 19939637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted drug delivery to the virus-infected airway; complications and remedies.
    Clarke DT; McMillan NA
    Curr Drug Deliv; 2015; 12(1):86-97. PubMed ID: 25233122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options.
    Zumla A; Memish ZA; Maeurer M; Bates M; Mwaba P; Al-Tawfiq JA; Denning DW; Hayden FG; Hui DS
    Lancet Infect Dis; 2014 Nov; 14(11):1136-1149. PubMed ID: 25189352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated antimicrobial dosing recommendations for obese patients.
    Castro-Balado A; Varela-Rey I; Mejuto B; Mondelo-García C; Zarra-Ferro I; Rodríguez-Jato T; Fernández-Ferreiro A
    Antimicrob Agents Chemother; 2024 May; 68(5):e0171923. PubMed ID: 38526051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local treatment of respiratory infections with antibiotics.
    Stout SA; Derendorf H
    Drug Intell Clin Pharm; 1987 Apr; 21(4):322-9. PubMed ID: 3552545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.
    Sherwin J; Heath T; Watt K
    Clin Ther; 2016 Sep; 38(9):1976-94. PubMed ID: 27553752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults.
    Kaiser L; Keene ON; Hammond JM; Elliott M; Hayden FG
    Arch Intern Med; 2000 Nov; 160(21):3234-40. PubMed ID: 11088083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled antibiotics for gram-negative respiratory infections.
    Hudson R; Olson Blair B
    Future Med Chem; 2011 Oct; 3(13):1663-77. PubMed ID: 21942255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled Antibiotics for Ventilator-Associated Infections.
    Palmer LB
    Infect Dis Clin North Am; 2017 Sep; 31(3):577-591. PubMed ID: 28779834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel amikacin inhaled formulation for the treatment of lower respiratory tract infections.
    Antoniu S; Azoicai D
    Drugs Today (Barc); 2013 Nov; 49(11):683-92. PubMed ID: 24308015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections.
    Merchant Z; Buckton G; Taylor KM; Stapleton P; Saleem IY; Zariwala MG; Somavarapu S
    Curr Pharm Des; 2016; 22(17):2577-98. PubMed ID: 26983671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.